AAAAAA

   
Results: 1-11 |
Results: 11
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma
Authors: Duvic, M Olsen, EA Omura, GA Maize, JC Vonderheid, EC Elmets, CA Shupack, JL Demierre, MF Kuzel, TM Sanders, DY
Citation: M. Duvic et al., A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma, J AM ACAD D, 44(6), 2001, pp. 940-947
Increased interleukin 5 production in eosinophilic Sezary syndrome: Regulation by interferon alfa and interleukin 12
Authors: Suchin, KR Cassin, M Gottleib, SL Sood, S Cucchiara, AJ Vonderheid, EC Rook, AH
Citation: Kr. Suchin et al., Increased interleukin 5 production in eosinophilic Sezary syndrome: Regulation by interferon alfa and interleukin 12, J AM ACAD D, 44(1), 2001, pp. 28-32
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome)
Authors: Vonderheid, EC Bigler, RD Kotecha, A Boselli, CM Lessin, SR Bernengo, MG Polansky, M
Citation: Ec. Vonderheid et al., Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome), J INVES DER, 117(3), 2001, pp. 654-662
Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome)
Authors: Galindo, LM Garcia, FU Hanau, CA Lessin, SR Jhala, N Bigler, RD Vonderheid, EC
Citation: Lm. Galindo et al., Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome), AM J CLIN P, 113(6), 2000, pp. 865-871
0Mycosis fungoides with CD30-positive cells in the epidermis
Authors: Wu, H Telang, GH Lessin, SR Vonderheid, EC
Citation: H. Wu et al., 0Mycosis fungoides with CD30-positive cells in the epidermis, AM J DERMAT, 22(3), 2000, pp. 212-216
Relative frequency of various forms of primary cutaneous lymphomas
Authors: Zackheim, HS Vonderheid, EC Ramsay, DL LeBoit, PE Rothfleisch, J Kashani-Sabet, M
Citation: Hs. Zackheim et al., Relative frequency of various forms of primary cutaneous lymphomas, J AM ACAD D, 43(5), 2000, pp. 793-796
Sarcoidal tissue reaction in Sezary syndrome
Authors: Gregg, PJ Kantor, GR Telang, GH Lessin, SR Nowell, PC Vonderheid, EC
Citation: Pj. Gregg et al., Sarcoidal tissue reaction in Sezary syndrome, J AM ACAD D, 43(2), 2000, pp. 372-376
Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein
Authors: Abrams, JT Vonderheid, EC Kolbe, S Appelt, DM Arking, EJ Balin, BJ
Citation: Jt. Abrams et al., Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein, CL DIAG LAB, 6(6), 1999, pp. 895-905
p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: A study of 12 cases
Authors: Marrogi, AJ Khan, MA Vonderheid, EC Wood, GS McBurney, E
Citation: Aj. Marrogi et al., p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: A study of 12 cases, J CUT PATH, 26(8), 1999, pp. 369-378
Multinucleate-cell angiohistiocytoma occurring in a patient with mycosis fungoides
Authors: Bader, RS Telang, GH Vonderheid, EC
Citation: Rs. Bader et al., Multinucleate-cell angiohistiocytoma occurring in a patient with mycosis fungoides, CUTIS, 63(3), 1999, pp. 145-148
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses
Authors: Rook, AH Wood, GS Yoo, EK Elenitsas, R Kao, DMF Sherman, ML Witmer, WK Rockwell, KA Shane, RB Lessin, SR Vonderheid, EC
Citation: Ah. Rook et al., Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses, BLOOD, 94(3), 1999, pp. 902-908
Risultati: 1-11 |